Research Article

Total Psoas Area Predicts Complications following Radical Cystectomy

Table 1

Patient characteristics.

90-day complicationNo complication value

Age, years, mean ± SD68.5 ± 9.969.1 ± 9.40.71
Gender (%)0.99
 M60 (80)48 (80)
 F15 (20)12 (20)
Race (%)0.37
 White69 (92)58 (97)
 Nonwhite6 (8.0)2 (3.3)
Smoker (%)51 (68)37 (62)0.56
BMI, kg/m2, median (IQR)26.2 (22.5–30.4)25.3 (22.8–29.0)0.45
Serum albumin, g/dL, median (IQR) 3.7 (3.0–4.0)3.8 (3.4–4.0)0.22
Charlson comorbidity index0.11
 0-128 (37)30 (50)
 2-326 (35)24 (40)
321 (28)6 (10)
Neoadjuvant chemotherapy (%)13 (17)7 (12)0.36
L3 TPA, cm2/m2, median (IQR)7.8 (6.6–9.5)8.8 (7.5–10.1)0.023
Diversion type (%)0.69
 Neobladder21 (28)18 (30)
 Continent cutaneous4 (5.3)1 (1.7)
 Ileal conduit48 (64)41 (68)
 No diversion (anephric)1 (1.3)0
Pathologic T Stage (%)0.23
 T01 (1.3)2 (3.3)
 Ta04 (6.7)
 Tis8 (11)6 (10)
 T15 (6.7)8 (13)
 T214 (19)9 (15)
 T330 (40)22 (37)
 T417 (23)9 (15)
Node positive (%)23 (31)14 (23)0.16
Operative time, min, mean ± SD356 ± 103334 ± 930.20
Estimated blood loss, mL, median (IQR)850 (550–1075)850 (675–1525)0.56

SD: standard deviation, IQR: interquartile range, GFR: glomerular filtration rate, TPA: total psoas area, and mL: milliliter.
.